Invention Grant
- Patent Title: Sustained-release formulations of colchicine and methods of using same
-
Application No.: US16594543Application Date: 2019-10-07
-
Publication No.: US11648206B2Publication Date: 2023-05-16
- Inventor: Susanne Riel
- Applicant: Murray and Poole Enterprises, LTD.
- Applicant Address: GB Gibraltar
- Assignee: MURRAY AND POOLE ENTERPRISES LTD
- Current Assignee: MURRAY AND POOLE ENTERPRISES LTD
- Current Assignee Address: GI Gibraltar
- Agency: BioPharma Law Group, PLLC
- Priority: EP 194505 2013.11.26
- The original application number of the division: US14563503 2014.12.08
- Main IPC: A61K31/165
- IPC: A61K31/165 ; A61K45/06 ; A61K47/02 ; A61K47/12 ; A61K47/26 ; A61K47/36 ; A61K47/38 ; A61K9/20

Abstract:
Pharmaceutical compositions of colchicine for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined or desired release profile. Methods of treating or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects comprising the administration of the novel formulations disclosed herein are also provided.
Public/Granted literature
- US20200030240A1 SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME Public/Granted day:2020-01-30
Information query